Abstract
CYSTIC FIBROSIS - Ethical issues at two extremes
Emma Farrar and Jemma Smith worked as medical students with consultant paediatrician Clare Peckham at a time when services for cystic fibrosis were undergoing a transformation. Clare herself is leading the local service development. Neonatal screening for cystic fibrosis started in the North West on 1 October 2007.
The right of a child to be involved in decision making concerning his or her future has recently been affirmed by the General Medical Council. These events provide the backdrop to two timely articles on the ethical issues involved in the management of a difficult illness.
References
Cystic Fibrosis Trust. What is cystic fibrosis. Available from: https://www.cysticfibrosis.org.uk/what-is-cystic-fibrosis
Newborn bloodspot screening. Available from: http://www.newbornscreening-bloodspot.org.uk/
National standard protocol for newborn screening for cystic fibrosis – algorithm. Institute of Child Health; October 2005. Available from: http://www.ich.ucl.ac.uk/newborn/download/national_std_protocol_algorithm.ppt#256,1,Slide1
Information Sheet. Why are newborn babies screened for cystic fibrosis? UK Newborn Screening Programme Centre; 2005. Available from: http://www.newbornscreening-bloodspot.org.uk/
Hope T, Savulescu J, Hendrick J. Medical Ethics and Law. Churchill Livingstone. 2003
Mischler EH, Wilfond BS, Fost N, et al. Cystic fibrosis newborn screening: impact on reproductive behaviour and implications for genetic counselling. Paediatrics 1998;102(1Pt 1):44-52. Available from: https://doi.org/10.1542/peds.102.1.44
Sawyer SM, Cerritelli B, Carter LS, et al. Changing their minds with time: a comparison of hypothetical and actual reproductive behaviours in parents of children with cystic fibrosis. Paediatrics 2006;118(3):e649-5. Available from: https://doi.org/10.1542/peds.2005-25516
Farrell PM, Li Z, Kosorok MR, et al. Bronchopulmonary disease in children with cystic fibrosis after early or delayed diagnosis. Am J Respir Crit Care Med 2003;168(9):1100-8. Available from: https://doi.org/10.1164/rccm.200303-434OC
Baussano I, Tardivo I, Bellezza-Fontana R, et al. Neonatal screening for cystic fibrosis does not affect time to first infection with Pseudomonas aeruginosa. Paediatrics 2006;118(3):888-95. Available from: https://doi.org/10.1542/peds.2004-2599
Farrell PM, Lai HJ, Li Z, et al. Evidence on improved outcomes with early diagnosis of cystic fibrosis through neonatal screening: enough is enough! J Pediatr 2005;147(3 Suppl):S30-6. Available from: https://doi.org/10.1016/j.jpeds.2005.08.012
Sims EJ, Clark A, McCormick J, et al. Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy. Paediatrics 2007;119(1):19-28. Available from: https://doi.org/10.1542/peds.2006-1498
Sims EJ, McCormick J, Mehta G, Mehta A, UK CF Database Steering Committee. Newborn screening for cystic fibrosis is associated with decreased treatment intensity. J Pediatr 2005;147(3):306-11. Available from: https://doi.org/10.1016/j.jpeds.2005.05.034
Grosse SD, Rosenfeld M, Devine OJ, Lai HJ, Farrell PM. Potential impact of newborn screening for cystic fibrosis on child survival: a systematic review and analysis. J Pediatr 2006;149(3):362-6. Available from: https://doi.org/10.1016/j.jpeds.2006.04.059
Tluczek A, Koscik RL, Farrell PM, Rock MJ. Psycho-social risk associated with newborn screening for cystic fibrosis: parent’s experience while awaiting the sweat-test appointment. Paediatrics 2005;115(6):1692-703. Available from: https://doi.org/10.1542/peds.2004-0275
Southern KW, Munck A, Pollitt R, et al. A survey of newborn screening for cystic fibrosis in Europe. J Cyst Fibros 2007;6(1):57-65. Available from: https://doi.org/10.1016/j.jcf.2006.05.008